$7.56
arrow_drop_down1.81%Key Stats | |
---|---|
Open | $7.69 |
Prev. Close | $7.70 |
EPS | -7,067.85 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $7.96M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 7.50 | 7.90 |
52 Week Range | 3.95 | 71.04 |
Ratios | |
---|---|
EPS | -7,067.85 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer - GlobeNewswire
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year?
Is Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Year?
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates